Clinical Trial Update: Allogeneic ABCB5-positive Limbal Stem Cells for Treatment of LSCD [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating allogeneic ABCB5-positive limbal stem cells for treatment of limbal stem cell deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limbal Stem Cell Deficiency

Drugs mentioned

• ABCB5-positive limbal stem cells (ABCB5-positive limbal stem cells)

Snippet

Sponsor: RHEACELL GmbH & Co. KG | Conditions: Limbal Stem Cell Deficiency | Phase 1, Phase 2 | Status: UNKNOWN